rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gregory Reyes

Director

Company insider

Files Form 4 as: Director, Artelo Biosciences; Senior VP, Research, Bio Green Med Solution.

Every Form 4 they filed

In numbers

Trades disclosed
24
Buys
1
Sells
0
Bought
$8,700
Sold
$0
Companies
2
Companies where not an officer
1
First trade
22 Jun 2007
Last trade
17 Jul 2026
Last filed
21 Jul 2026

Companies traded

Where they are an officer
BGMS Bio Green Med SolutionOfficer · Distributors & Wholesale · last 20 Mar 20081 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ARTL Artelo BiosciencesDirector · Biotechnology · last 17 Jul 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jul 2026filed 21 Jul 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—136 at $0.00filing
17 Jul 2026filed 21 Jul 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—136 at $0.00filing
30 Jan 2026filed 2 Feb 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—292 at $0.00filing
30 Jan 2026filed 2 Feb 2026ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—292 at $0.00filing
20 Dec 2024filed 23 Dec 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,750 at $0.00filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—8,000filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,083filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—8,000filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667filing
28 Feb 2024filed 1 Mar 2024ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,083filing
4 Aug 2023filed 8 Aug 2023ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,083 at $0.00filing
30 Jun 2023filed 3 Jul 2023ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—667 at $0.00filing
24 Jun 2022filed 27 Jun 2022ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
16 Jul 2021filed 26 Jul 2021ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
4 Dec 2020filed 7 Dec 2020ARTL Artelo Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—120,000 at $0.00filing

News

Ashtead Group (OTCMKTS:ASHTY) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS) Critical ReviewBGMS · themarketsdaily.com · 18 Oct 2026

0 headlines in the last 90 days name Gregory Reyes; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Industrials1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.